Publicaties
2025
Wetenschappelijke publicaties
Hasanefendic, S., Hoogstraaten, M., Bloemendal, M., Boon, W., Brezet, H., Chappin, M. M. H., Coenen, L., Dai, Y., Elzinga, R., Femenías, P., Frishammar, J., van der Grijp, N., van Hal, A., von Hauff, E., Heller, R., Hellsmark, H., Hoppe, T., Isabella, O., Janssen, M., ... Bossink, B. (2025). Sustainable energy experiments and demonstrations: Reviewing research, market and societal trends. Energy Research and Social Science, 122, Article 104018. [DOI] [Portal]
2024
Wetenschappelijke publicaties
Lukkien, D. R. M., Askari, S. I., Stolwijk, N. E., Hofstede, B. M., Nap, H. H., Boon, W. P. C., Peine, A., Moors, E. H. M., & Minkman, M. M. N. (2024). Making Co-Design More Responsible: Case Study on the Development of an AI-Based Decision Support System in Dementia Care. JMIR Human Factors, 11, Article e55961. [DOI] [Portal]
Lukkien, D. R. M., Stolwijk, N. E., Ipakchian Askari, S., Hofstede, B. M., Nap, H. H., Boon, W. P. C., Peine, A., Moors, E. H. M., & Minkman, M. M. N. (2024). AI-Assisted Decision-Making in Long-Term Care: Qualitative Study on Prerequisites for Responsible Innovation. JMIR Nursing, 7(1), Article e55962. [DOI] [Portal]
Douglas, C., & Boon, W. (2024). Social pharmaceutical innovation: findings from international collaborative project. Paper presented at EASST-4S 2024 Conference, Amsterdam, Netherlands. https://nomadit.co.uk/conference/easst-4s2024/paper/85618
Egher, C., Boon, W., & van Hees, S. (2024). Moral labor and the (re)turn of values in the development of research infrastructures: Trading and re-configuring valuation practices in the co-creation of a data infrastructure for rare cancers. Paper presented at EASST-4S 2024 Conference, Amsterdam, Netherlands. https://nomadit.co.uk/conference/easst-4s2024/paper/85580
Wijne, T., Moors, E., Boon, W., & Hoekman, J. (2024). Creating societal impact through impact practices in large-scale trandisciplinary research projects. Paper presented at EASST-4S 2024 Conference, Amsterdam, Netherlands.
Meijer, A., & Boon, W. (2024). Digital platforms for the co-creation of public value. In J. Torfing, E. Ferlie, T. Jukić, & E. Ongaro (Eds.), Strategic Management of the Transition to Public Sector Co-Creation (pp. 50-70). Policy Press. [DOI]
Lukkien, D. R. M., Stolwijk, N. E., Askari, S. I., Hofstede, B. M., Nap, H. H., Boon, W. P. C., Peine, A., Moors, E. H. M., & Minkman, M. M. N. (2024). Artificial intelligence-assisted decision-making in long-term care: a qualitative study on opportunities and prerequisites for responsible innovation (Preprint). JMIR Human Factors. [DOI] [Repository]
Kleinhout-Vliek, T. H., Boon, W. P. C., Hagendijk, R. P., Hoekman, J., & Moors, E. H. M. (2024). Together for the greater goods: legitimising social innovation in the pharmaceutical field. Innovation: The European Journal of Social Science Research, 37(1), 60-84. [DOI] [Repository]
Hees, S. V., Kleinloog, J. P. D., Sbrizzi, A., & Boon, W. P. C. (2024). Static Future Technologies, Dynamic Professionalism — Co-creating Future Scenarios in Medical Imaging Practices. Postdigital Science and Education, 6(1), 135-153. [DOI] [Repository]
2023
Wetenschappelijke publicaties
Boon, W., & Kleinhout - Vliek, T. (2023). Experiments as a form of social pharmaceutical innovation. Abstract from International Sustainability Transitions Conference, Utrecht, Netherlands.
Lukkien, D., Askari, S. I., Stolwijk, N., Hofstede, B., Nap, H. H., Boon, W., Peine, A., Moors, E., & Minkman, M. (2023). Making co-design more responsible: a case study on developing an AI-based decision support system in dementia care (Preprint). JMIR Human Factors. [DOI]
Tol, M. C., de Bont, D. F. A., Boon, W. P. C., de Koning, E. J. P., & van Apeldoorn, A. A. (2023). Preferred Islet Delivery Device Characteristics and Implantation Strategies of Patients With Type 1 Diabetes. Transplant International, 36, Article 11077. [DOI] [Repository]
van Beest, W., Boon, W. P. C., Andriessen, D., Zielhuis, M., van der Veen, G., & Moors, E. H. M. (2023). How to involve potential users in eHealth innovation: seven strategies from healthcare and design. Design for Health, 7(3), 307-325. [DOI]
Cao, V. A. T., Nguyen, T. Q., Le Quyen, D., Boon, W. P. C., Moors, E. H. M., Dondorp, A. M., de Haan, F., & Amaratunga, C. (2023). Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam. Malaria Journal, 22(1), 1-8. Article 326. [DOI] [Repository]
Yuana, S. L., Boon, W., Raven, R., Hajer, M. A., Sengers, F., & Ghosh, B. (2023). Pluralizing urban futures: A multicriteria mapping analysis of online taxis in Indonesia. Futures, 154, 1-12. Article 103260. [DOI] [Repository]
Guissou, R. M., Amaratunga, C., de Haan, F., Tou, F., Cheah, P. Y., Yerbanga, R. S., Moors, E. H. M., Dhorda, M., Tindana, P., Boon, W. P. C., Dondorp, A. M., & Ouédraogo, J. B. (2023). The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso. Malaria Journal, 22(1), Article 269. [DOI] [Repository]
de Haan, F., Amaratunga, C., Thi, V. A. C., Orng, L. H., Vonglokham, M., Quang, T. N., Lek, D., Boon, W. P. C., Dondorp, A. M., & Moors, E. H. M. (2023). Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion. Malaria Journal, 22(1), 1-11. Article 261. [DOI] [Repository]
van de Burgwal, L., van der Valk, T., Kempter, H., Gadau, M., Stubbs, D., & Boon, W. (2023). An elephant in the glasshouse? Trade-offs between acceleration and transformation in COVID-19 vaccine innovation policies. Environmental Innovation and Societal Transitions, 48, Article 100736. [DOI] [Repository]
Ferreira, G. S., Dijkstra, F. M., Veening-Griffioen, D. H., Boon, W. P. C., Schellekens, H., Moors, E. H. M., van Meer, P. J. K., Stuurman, F. E., & van Gerven, J. M. A. (2023). Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational Psychiatry, 13(1), Article 74. [DOI] [Repository]
Hoogstraaten, M., Frenken, K., Vaskelainen, T., & Boon, W. (2023). Replacing meat, an easy feat? The role of strategic categorizing in the rise of meat substitutes. Environmental Innovation and Societal Transitions, 47, Article 100703. [DOI] [Repository]
Lukkien, D. R. M., Nap, H. H., Buimer, H. P., Peine, A., Boon, W. P. C., Ket, J. C. F., Minkman, M. M. N., & Moors, E. H. M. (2023). Toward Responsible Artificial Intelligence in Long-Term Care: A Scoping Review on Practical Approaches. The Gerontologist, 63(1), 155-168. Article gnab180. [DOI] [Repository]
Vakpublicaties
European Commission, Directorate-General for Health and Food Safety, Mantel - Teeuwisse, A., Bloem, L. T., Boon, W., De Bruin, M. L., Hoekman, J., Klein, K., Stolk, P., & Vreman, R. (2023). Study in support of the evaluation and impact assessment of the EU general pharmaceuticals legislation: Analytical Report. Publications Office of the European Union. [DOI] [Repository]
European Commission, Directorate-General for Health and Food Safety, Mantel - Teeuwisse, A., Bloem, L. T., Boon, W., De Bruin, M. L., Hoekman, J., Klein, K., Stolk, P., & Vreman, R. (2023). Study in support of the evaluation and impact assessment of the EU general pharmaceuticals legislation: Evaluation Report. Publications Office of the European Union. [DOI] [Repository]
2022
Wetenschappelijke publicaties
Münzel, K., Arentshorst, M., Boon, W., & Frenken, K. (2022). Assessing policies to scale up carsharing. In B. van Wee, J. Annema, & J. Köhler (Eds.), Innovations in Transport: Success, Failure and Societal Impacts (pp. 242-268). Edward Elgar Publishing. [DOI] [Repository]
Kleinhout - Vliek, T., Boon, W., Hagendijk, R., Hoekman, J., & Moors, E. (2022). Causing headwinds? How Dutch actors conceive situated futures for magistral preparation of pharmaceuticals. Abstract from EASST 2022 (European Association for the Study of Science and Technology) , Madrid, Spain.
Boon, W., Magnusson, T., & Hyysalo, S. (2022). Introduction to ‘Markets in sustainability transitions’. Environmental Innovation and Societal Transitions, 45, 30-35. [DOI] [Repository]
Douglas, C. M. W., Aith, F., Boon, W., de Neiva Borba, M., Doganova, L., Grunebaum, S., Hagendijk, R., Lynd, L., Mallard, A., Mohamed, F. A., Moors, E., Oliveira, C. C., Paterson, F., Scanga, V., Soares, J., Raberharisoa, V., & Kleinhout-Vliek, T. (2022). Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases. Orphanet Journal of Rare Diseases, 17(1), 1-13. Article 344. [DOI] [Repository]
Hermans, A. M. M., Maliepaard, M., Boon, W. P. C., & Pasmooij, A. M. G. (2022). Impact of the new European Union In Vitro Diagnostics Regulation on the practice of hospital diagnostic laboratories. Expert Review of Molecular Diagnostics, 22(5), 583-590. [DOI] [Repository]
Douglas, C., Aith, F., Cordovil-Oliveira, C., Boon, W., Doganova, L., Hagendijk, R., Hoekman, J., Kleinhout - Vliek, T., Moors, E., Mallard, A., Paterson, F., Grunebaum, S., & Rabeharisoa, V. (2022). Social pharmaceutical innovation: Towards a interdisciplinary research agenda for drugs for rare diseases. Abstract from EU-SPRI Conference 2022, Utrecht, Netherlands.
Kleinhout - Vliek, T., Boon, W., Hagendijk, R., Hoekman, J., & Moors, E. (2022). Legitimising Dutch Social Pharmaceutical Innovation. Abstract from EU-SPRI Conference 2022, Utrecht, Netherlands.
Boon, W., Edler, J., & Robinson, D. (2022). Market formation for societal challenges – exploring policy interventions. Abstract from EU-SPRI Conference 2022, Utrecht, Netherlands.
Robinson, D., Borràs, S., & Boon, W. (2022). Reimagining the diffusion of innovation: generalisation as a key element of policies for transformative change. Abstract from EU-SPRI Conference 2022, Utrecht, Netherlands.
de Haan, F., Boon, W. P. C., Amaratunga, C., & Dondorp, A. M. (2022). Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study. BMC Public Health, 22(1), 1-14. Article 864. [DOI] [Repository]
Hoop, E. D., Boon, W., Oers, L. V., Smith, A., Späth, P., & Raven, R. (2022). Deliberating the knowledge politics of smart urbanism. Urban Transformations, 4, 1-15. Article 6. [DOI] [Repository]
Boon, W. P. C., Edler, J., & Robinson, D. K. R. (2022). Conceptualizing market formation for transformative policy. Environmental Innovation and Societal Transitions, 42, 152-169. [DOI] [Repository]
Boon, W., de Haan, J. J., van Sebille, E., Gould, L., Janssen, W., Jongsma, K. R., Milota, M., Maud, R., Stevens, S., Strick, M., Swinkels, M., Wanders, N., & Yerkes, M. (2022). Meaningful public engagement in the context of open science: reflections of early and mid-career academics. Research for All, 6(1), 1-8. [DOI] [Repository]
van Beest, W., Boon, W. P. C., Andriessen, D., Pol, H., van der Veen, G., & Moors, E. H. M. (2022). A Research Pathway Model for evaluating the implementation of practice-based research: The case of self-management health innovations. Research Evaluation, 31(1), 24-48. [DOI] [Repository]
Vaskelainen, T., Münzel, K., Boon, W., & Frenken, K. (2022). Servitisation on consumer markets: entry and strategy in Dutch private lease markets. Innovation: Organization and Management, 24(1), 231-250. [DOI] [Repository]
van Beest, W., Boon, W. P. C., Andriessen, D., Moors, E. H. M., van der Veen, G., & Pol, H. (2022). Successful implementation of self-management health innovations. Journal of Public Health , 30(3), 721-735. [DOI] [Repository]
2021
Wetenschappelijke publicaties
Boon, W. (2021). Transformative missions in healthcare – the case of preventive healthcare in the Netherlandss. Abstract from Eu-SPRI Annual Conference 2021, Oslo, Norway.
Yuana, S. L., Sengers, F., Boon, W., Hajer, M., Raven, R., & Ghosh, B. (2021). Politics of Futures in Urban Mobility Transitions: A Multi-Criteria Mapping Analysis of Online Taxis in Indonesia. Abstract from Eu-SPRI Annual Conference 2021, Oslo, Norway.
Kleinhout - Vliek, T., Arentshorst, M., Kalkman, S., Boon, W., Hagendijk, R., Hoekman, J., & Moors, E. (2021). Causing headwinds? How Dutch actors conceive situational futures for magistral preparation of pharmaceuticals. Paper presented at Society for Social Studies of Science (4S) 2021 Annual meeting, "Virtual Toronto".
Boon, W., Duisterwinkel, C., Strick, M., & Thunnissen, M. (2021). Open Science & Stakeholder Engagement: Why, how, and what could be improved? Utrecht University. https://www.uu.nl/sites/default/files/Open%20Science%20Stakeholder%20Engagement%20-%20exploratory%20study%20report.pdf [Repository]
Boon, W. P. C., & van Wee, B. (2021). 3D Printers and Transport. In R. Vickerman (Ed.), International Encyclopedia of Transportation (pp. 471-478). Elsevier. [DOI] [Repository]
de Haan, F., Bolarinwa, O. A., Guissou, R., Tou, F., Tindana, P., Boon, W. P. C., Moors, E. H. M., Cheah, P. Y., Dhorda, M., Dondorp, A. M., Ouedraogo, J. B., Mokuolu, O. A., & Amaratunga, C. (2021). To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies? PLoS One, 16(8), 1-17. Article e0256567. [DOI] [Repository]
de Haan, F., Moors, E. H. M., Dondorp, A. M., & Boon, W. P. C. (2021). Market Formation in a Global Health Transition. Environmental Innovation and Societal Transitions, 40, 40-59. [DOI] [Repository]
Meijer, A., & Boon, W. (2021). Digital platforms for the co-creation of public value. Policy and Politics, 49(2), 231-248. [DOI] [Repository]
Tindana, P., de Haan, F., Mokuolu, OA., Guissou, R., Bolarinwa, OA., Ouedraogo, JB., Tou, F., Boon, WPC., Moors, EHM., Dondorp, AM., Dhorda, M., Amaratunga, C., & Cheah, PY. (2021). Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol. Wellcome Open Research, 6(75). [DOI] [Repository]
Veening-Griffioen, D. H., Ferreira, G. S., Boon, W. P. C., Gispen-de Wied, C. C., Schellekens, H., Moors, E. H. M., & Van Meer, P. J. K. (2021). Tradition, not science, is the basis of animal model selection in translational and applied research. Altex, 38(1), 49-62. [DOI] [Repository]
Vakpublicaties
Boon, W., Verkade, N., Hoekman, J., van der Voort, T., & Moors, E. (2021). Innovation pathways to achieve the moonshot for proof-of-concept therapy for type 1 diabetes. (deliverable 5.3 ‘adapted ELSA’ ed.) RegMed XB .
2020
Wetenschappelijke publicaties
Schilder, I. PA., Veening-Griffioen, D. H., Ferreira, G. S., Meer, P. JK. V., Wied, C. C. G., Schellekens, H., Boon, W. PC., & Moors, E. HM. (2020). Pathways in the Drug Development for Alzheimer's Disease (1906-2016): A Bibliometric Study. Journal of Scientometric Research, 9(3), 277-292. [DOI] [Repository]
Hoogstraaten, M. J., Boon, W. P. C., & Frenken, K. (2020). How product development partnerships support hybrid collaborations dealing with global health challenges. Global Transitions, 2, 190-201. [DOI] [Repository]
Yuana, S. L., Sengers, F., Boon, W., Hajer, M. A., & Raven, R. (2020). A dramaturgy of critical moments in transition: Understanding the dynamics of conflict in socio-political change. Environmental Innovation and Societal Transitions, 37, 156-170. [DOI] [Repository]
Yuana, Y., Sengers, F., Boon, W. P. C., Hajer, M. A., & Raven, R. (2020). Informal regime maintenance: exploring strategies of Indonesia’s informal motorbike taxi in the face of the digital innovation. Paper presented at The 11th International Sustainability Transition conference (IST).
Yuana, Y., Sengers, F., Boon, W. P. C., Hajer, M. A., & Raven, R. (2020). A Dramaturgy of Critical Moments in Transition: Understanding the dynamics of conflict in socio-political change. Paper presented at The 11th International Sustainability Transition conference (IST).
Magnusson, T., & Boon, W. P. C. (2020). Markets in sustainability transitions. Paper presented at The 11th International Sustainability Transition conference (IST).
Ferreira, G. S., Veening-Griffioen, D. H., Boon, W. P. C., Moors, E. H. M., & van Meer, P. J. K. (2020). Levelling the Translational Gap for Animal to Human Efficacy Data. Animals, 10(7), Article 1199. [DOI] [Repository]
Hoogstraaten, M. J., Frenken, K., & Boon, W. P. C. (2020). The study of institutional entrepreneurship and its implications for transition studies. Environmental Innovation and Societal Transitions, 36, 114-136. [DOI] [Repository]
Strohm, L., Hehakaya, C., Ranschaert, E. R., Boon, W. P. C., & Moors, E. H. M. (2020). Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors. European Radiology, 30, 5525-5532. [DOI] [Repository]
Ferreira, G. S., Veening-Griffioen, D. H., Boon, W. P. C., Hooijmans, C. R., Moors, E. H. M., Schellekens, H., & van Meer, P. J. K. (2020). Comparison of drug efficacy in two animal models of type 2 diabetes: A systematic review and meta-analysis. European Journal of Pharmacology, 879, Article 173153. [DOI] [Repository]
van Welie, M. J., Boon, W. P. C., & Truffer, B. (2020). Innovation system formation in international development cooperation: The role of intermediaries in urban sanitation. Science and Public Policy, 47(3), 333-347. [DOI] [Repository]
van Lente, H., Boon, W. P. C., & Klerkx, L. (2020). Positioning of systemic intermediaries in sustainability transitions: Between storylines and speech acts. Environmental Innovation and Societal Transitions, 36, 485-497. [DOI] [Repository]
Elzinga, R., Reike, D., Negro, S. O., & Boon, W. P. C. (2020). Consumer acceptance of circular business models. Journal of Cleaner Production, 254, Article 119988. [DOI] [Repository]
Boon, W. P. C., Edler, J., & Robinson, D. K. R. (2020). Market formation in the context of transitions: a comment on the transitions agenda. Environmental Innovation and Societal Transitions, 34, 346-347. [DOI] [Repository]
Kalkman, S., Arentshorst, M., Hoekman, J., Boon, W., Uijtendaal, E., van Thiel, G., & Moors, E. (2020). In-Hospital Production of Medicines: Preparing for Disruption. Trends in Biotechnology, 38(10), 1045-1047. [DOI] [Repository]
Münzel, K., Boon, W., Frenken, K., Blomme, J., & van der Linden, D. (2020). Explaining carsharing supply across Western European cities. International Journal of Sustainable Transportation, 14(4), 243-254. [DOI] [Repository]
2019
Wetenschappelijke publicaties
Amaratunga, C., Dhorda, M., Van Der Pluijm, R., Tarning, J., Aguas, R., Boni, M. F., Cheah, P. Y., Tindana, P., De Haan, F., Boon, W., Moors, E. H., Plewes, K., Tripura, R., Day, N. P., White, N. J., & Dondorp, A. M. (2019). Triple artemisinin combination therapies: A new paradigm for the treatment of malaria? American Journal of Tropical Medicine and Hygiene, 101(5), 583. [DOI] [Repository]
de Hoop, E., van Oers, L. M., Becker, S., Macrorie, R., Spaeth, P., Astola, M., & Boon, W. P. C. (2019). Smart as a Global Vision? Exploring Smart in Local District Development Projects. Architecture and Culture, 7(2), 1-19. [DOI] [Repository]
Boon, W. P. C., Hollants, B., van den Berg, S., Schuurmans, E., & Hoekman, J. (2019). Kennisagenda zeldzame ziekten: Multi-stakeholder expertstudie naar kennisprioriteiten. Utrecht University. [Repository]
Ferreira, G. S., Veening-Griffioen, D. H., Boon, W. P. C., Moors, E. H. M., Gispen-de Wied, C. C., Schellekens, H., & van Meer, P. J. K. (2019). Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development. PLoS One, 14(7), Article e0220325. [DOI] [Repository]
Gispen-de Wied, C. C., Weemers, J., Boon, W., Mol, P. G. M., & Stolk, P. (2019). Future of the drug label: perspectives from a multi stakeholder dialogue. British Journal of Clinical Pharmacology, 85(10), 2442-2445. [DOI] [Repository]
Münzel, K., Piscicelli, L., Boon, W. P. C., & Frenken, K. (2019). Different business models – different users? Uncovering the motives and characteristics of business-to-consumer and peer-to-peer carsharing adopters in The Netherlands. Transportation Research Part D: Transport and Environment, 73, 276-306. [DOI] [Repository]
Veening-Griffioen, D. H., Ferreira, G. S., van Meer, P. J. K., Boon, W. P. C., Gispen-de Wied, C. C., Moors, E. H. M., & Schellekens, H. (2019). Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease. European Journal of Pharmacology, 859, 1-12. Article 172524. [DOI] [Repository]
Boon, W. P. C., Spruit, K., & Frenken, K. (2019). Collective institutional work: the case of Airbnb in Amsterdam, London and New York. Industry and Innovation, 26(8), 898-919. [DOI] [Repository]
Boon, W. P. C., Hessels, L. K., & Horlings, E. (2019). Knowledge co-production in protective spaces: case studies of two climate adaptation projects. Regional Environmental Change, 19(7), 1935–1947 . [DOI] [Repository]
S. Ferreira, G., Veening-Griffioen, D. H., Boon, W. P. C., Moors, E. H. M., Gispen-de Wied, C. C., Schellekens, H., & van Meer, P. J. K. (2019). A standardised framework to identify optimal animal models for efficacy assessment in drug development. PLoS One, 14(6), Article e0218014. [DOI] [Repository]
Boon, W. P. C., Edler, J., & Robinson, D. (2019). Dynamics of market formation: a new approach for analyzing innovation-initiated emergence of new markets. Paper presented at EU-SPRI 2019 Conference, Rome, Italy.
Pelzer, P., Frenken, K., & Boon, W. P. C. (2019). Institutional entrepreneurship in the platform economy: How Uber tried (and failed) to change the Dutch taxi law. Environmental Innovation and Societal Transitions, 33, 1-12. [DOI] [Repository]
Kivimaa, P., Hyysalo, S., Boon, W., Klerkx, L., Martiskainen, M., & Schot, J. (2019). Passing the baton: How intermediaries advance sustainability transitions in different phases. Environmental Innovation and Societal Transitions, 31, 110-125. [DOI] [Repository]
Yuana, S. L., Sengers, F., Boon, W., & Raven, R. (2019). Framing the sharing economy: A media analysis of ridesharing platforms in Indonesia and the Philippines. Journal of Cleaner Production, 212, 1154-1165. [DOI] [Repository]
Hoekman, J., & Boon, W. (2019). Changing standards for drug approval: A longitudinal analysis of conditional marketing authorisation in the European Union. Social Science & Medicine, 222, 76-83. [DOI] [Repository]
Kivimaa, P., Boon, W., Hyysalo, S., & Klerkx, L. (2019). Towards a typology of intermediaries in sustainability transitions: A systematic review and a research agenda. Research Policy, 48(4), 1062-1075. [DOI] [Repository]
Robinson, D. K. R., Lagnau, A., & Boon, W. P. C. (2019). Innovation pathways in additive manufacturing: Methods for tracing emerging and branching paths from rapid prototyping to alternative applications. Technological Forecasting and Social Change, 146, 733-750. [DOI] [Repository]
2018
Wetenschappelijke publicaties
Boon, W. P. C., & Sloots, F. (2018). Monitoring pilot versnellingsmakelaars: Evaluatie ondersteuning van opschaling eHealth-innovaties. Universiteit Utrecht. [Repository]
de Hoop, E., Smith, A., Boon, W. P. C., Macrorie, R., Marvin, S., & Raven, R. P. J. M. (2018). Chapter 3: Smart urbanism in Barcelona: a knowledge politics perspective. In J. Stissing Jensen, M. Cashmore, & P. Späth (Eds.), The Politics of Urban Sustainability Transitions: Knowledge, Power and Governance, 1st Edition (pp. 33-52). (Routledge Research in Sustainable Urbanism). Routledge.
Van Oers, L. M., Boon, W. P. C., & Moors, E. H. M. (2018). The creation of legitimacy in grassroots organisations: A study of Dutch community supported agriculture. Environmental Innovation and Societal Transitions, 29, 55-67. [DOI] [Repository]
te Kulve, H., Boon, W., Konrad, K., & Schuitmaker, T. J. (2018). Influencing the direction of innovation processes: The shadow of authorities in demand articulation. Science and Public Policy, 45(4), 455-467. [DOI] [Repository]
Boon, W., & Edler, J. (2018). Demand, challenges, and innovation: Making sense of new trends in innovation policy. Science and Public Policy, 45(4), 435-447. [DOI] [Repository]
Edler, J., & Boon, W. P. (2018). The next generation of innovation policy: Directionality and the role of demand-oriented instruments’: Introduction to the special section. Science and Public Policy, 45(4), 433-434. [DOI] [Repository]
Boon, W., & Van Wee, B. (2018). Influence of 3D printing on transport: a theory and experts judgment based conceptual model. Transport Reviews, 38(5), 556-575. [DOI] [Repository]
Moors, E. H. M., Kukk Fischer, P., Boon, W. P. C., Schellen, F., & Negro, S. O. (2018). Institutionalisation of markets: The case of personalised cancer medicine in the Netherlands. Technological Forecasting and Social Change, 128, 133-143. [DOI] [Repository]
Münzel, K. L., Boon, W. P. C., Frenken, K., & Vaskelainen, T. (2018). Carsharing business models in Germany: characteristics, success and future prospects. Information Systems and e-Business Management, 16(2), 271-291. [DOI] [Repository]
Overige resultaten
Moors, E. H. M., Arentshorst, M. E., Boon, W. P. C., & Hoekman, J. (2018). Transition to distributed sustainable innovation models. Paper presented at 9th International Sustainability Transitions Conference (IST) 2018, Manchester, United Kingdom.
Kivimaa, P., Hyysalo, S., Boon, W. P. C., Klerkx, L., Schot, J., & Martiskainen, M. (2018). How do intermediaries advance sustainability transitions? Conceptual insights on intermediary action in different transition phases. Paper presented at 9th International Sustainability Transitions Conference (IST) 2018, Manchester, United Kingdom.
Boon, W. P. C., & Moors, E. H. M. (2018). Innovation policy for distributed innovation models in healthcare. Abstract 24-2. Abstract from EU-SPRI 2018, Paris, France.
2017
Wetenschappelijke publicaties
Moors, E. H. M., Hoekman, J., Kalkman, S., Arentshorst, M. E., Boon, W. P. C., & van Thiel, G. (2017). From mass to modular innovation. Towards distributed drug development models. Paper presented at International workshop on medical innovation (WOMI 2017), Reykjavik, Iceland.
Boon, W. P. C., Evers, G. W., & Hoekman, J. (2017). Research-based innovation activities on rare diseases in the Netherlands. Utrecht University / ZonMW.
Kivimaa, P., Boon, W., & Antikainen, R. (2017). Commercialising university inventions for sustainability: A case study of (non-)intermediating 'cleantech' at Aalto University. Science and Public Policy, 44(5), 631-644. [DOI] [Repository]
Overige resultaten
Boon, W. P. C., Hoekman, J., Moors, E. H. M., & Evers, G. W. (2017). Innovation for rare diseases – co-creation in innovation ecosystems in the Netherlands. Paper presented at Eu-SPRI Annual Conference 2017, Vienna, Austria.
2016
Wetenschappelijke publicaties
de Vries, G., Boon, W., & Peine, A. (2016). User-led innovation in civic energy communities. Environmental Innovation and Societal Transitions, 19, 51-65. [DOI] [Repository]
Boon, W. P. C., & Bakker, S. (2016). Learning to shield - Policy learning in socio-technical transitions. Environmental Innovation and Societal Transitions, 18, 181-200. [DOI] [Repository]
Overige resultaten
Hoogstraaten, M. J., Boon, W. P. C., & de Vrueh, R. L. A. (2016). Innovation intermediaries: building bridges for global health (subtitle: Exploring the role of innovation intermediaries as institutional entrepreneurs in Product DevelopmentPartnerships for poverty-related diseases). Abstract from 2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden.
Hoekman, J., & Boon, W. P. C. (2016). Constructing regulatory niches for medicines that address unmet needs. Abstract from 2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden.
Moors, E. H. M., Kukk, P., Boon, W. P. C., & Negro, S. O. (2016). Institutionalisation of markets for innovative health technologies: The case of personalised cancer medicine in the Netherlands. Abstract from 2016 Eu-SPRI Conference “Exploring New Avenues for Innovation and Research Policies, Lund, Sweden.
2015
Wetenschappelijke publicaties
Arentshorst, M. E., de Cock Buning, T., Boon, W. P. C., & Broerse, J. E. W. (2015). ‘Prospecting responsible technology paths: Management options for an appropriate societal embedding of medical neuroimaging’. Science and Public Policy, 42(6), 775-788. [DOI] [Repository]
Boon, W. P. C., Aarden, E., & Broerse, J. E. W. (2015). Path creation by public agencies — The case of desirable futures of genomics. Technological Forecasting and Social Change, 99, 67-76. [DOI] [Repository]
De Haan, F., Onyamboko, M. A., Fanello, C. I., Woodrow, C. J., Lubell, Y., Boon, W. P. C., & Dondorp, A. M. (2015). Exploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo. Malaria Journal, 14(1), Article 963. [DOI] [Repository]
Hoekman, J., Boon, W., Bouvy, J. C., Ebbers, H. C., de Jong, J. P., & De Bruin, M. L. (2015). Use of the conditional marketing authorization pathway for oncology medicines in Europe. Clinical Pharmacology and Therapeutics, 98(5), 534-541. [DOI] [Repository]
Ebbers, H. C., Langedijk, J., Bouvy, J. C., Hoekman, J., Boon, W. P. C., de Jong, J. P., & De Bruin, M. L. (2015). An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe. European Journal of Clinical Pharmacology, 71(10). [DOI] [Repository]
Boon, W. P. C., Martins, L., & Koopmanschap, M. (2015). Governance of conditional reimbursement practices in the Netherlands. Health Policy, 119(2), 180-185. [DOI] [Repository]
Overige resultaten
de Vries, G., Peine, A., & Boon, W. P. C. (2015). Construction of user-driven configurations - lessons form Dutch civil energy communities. Abstract from 13th Annual Open and User Innovation Conference, Lisabon, Portugal.
Hoekman, J., & Boon, W. P. C. (2015). Balancing uncertainty and unmet need in pharmaceutical early access programs. 77. Abstract from The 24the Society for Risk Analysis Europe Conference, Maastricht, Netherlands.
2014
Wetenschappelijke publicaties
Boon, W. P. C., Bouvy, J. C., Broekmans, A. W., de Bruin, M. L., Ebbers, H. C., Hoekman, J., de Jong, J. P., Koopmanschap, M. A., Langedijk, J., & Stolk, P. (2014). Improving the EU system for the marketing authorisation of medicines: Learning from regulatory practice. Escher – The TI Pharma Platform for Regulatory Innovation. http://escher.lygature.org/fileadmin/media-archive/escher/Reports/Escher_report_IA.pdf
Boon, W. P. C., Chappin, M., & Perenboom, J. (2014). Balancing divergence and convergence in transdisciplinary research teams. Environmental Science & Policy, 40, 57-68. [DOI] [Repository]
Boon, W. P. C., Moors, E. H. M., & Meijer, A. J. (2014). Exploring dynamics and strategies of niche protection. Research Policy, 43(4), 792-803. [DOI] [Repository]
Hessels, L. K., Wardenaar, T., Boon, W. P. C., & Ploeg, M. (2014). The role of knowledge users in public-private research programs: An evaluation challenge. Research Evaluation, 23(2), 103-116. [DOI] [Repository]
Overige resultaten
Moors, E. H. M., Negro, S. O., Boon, W. P. C., Kukk, P., & Schellekens, H. (2014). Explaining the transition towards personalized health innovation systems. The case of personalized cancer treatment in the Netherlands. Abstract from 2014 Eu-SPRI Conference Science and Innovation Policy: Dynamics, Challenges, Responsibility and Practice, Manchester (UK), Manchester, United Kingdom.
Boon, W. P. C., Stolk, P., & Meijer, A. (2014). Off-label use of drugs as user innovation. Abstract from 2014 Eu-SPRI Conference Science and Innovation Policy: Dynamics, Challenges, Responsibility and Practice, Manchester (UK), Manchester, United Kingdom.
2013
Wetenschappelijke publicaties
Meijer, A., Boon, W., & Moors, E. (2013). Stakeholder engagement in pharmaceutical regulation: Connecting technical expertise and lay knowledge in risk monitoring. Public Administration, 91(3), 696-711. [DOI] [Repository]
Vakpublicaties
Boon, W. P. C., & Horlings, E. (2013). Kenniscoproductie voor de grote maatschappelijke vraagstukken. Rathenau Instituut. http://www.rathenau.nl/uploads/tx_tferathenau/Kenniscoproductie_Rathenau.pdf [Repository]
Boon, W. P. C. (2013). Vervroegde toelating van griepvaccins - tussen vaart en veiligheid. Podium voor Bio-ethiek, 20(1), 33-36. [Repository]
Overige resultaten
Boon, W. P. C., Horlings, E., & van den Besselaar, P. (2013). Governance of knowledge co-production in protective spaces. Abstract from 2013 EU-Spri Forum Conference, Madrid, Spain.
2012
Vakpublicaties
Boon, W., Smit, C., Evers, M. P. J., Meyboom, R. H. B., & Visser, E. (2012). Patiëntenparticipatie bij klinisch onderzoek. Pharmaceutisch Weekblad, 25, 14-18. [Repository]
Overige resultaten
Moors, E. H. M., Boon, W. P. C., & Meijer, A. J. (2012). Managing urgent innovations. Exploring restrictive and broad strategic nich management. Abstract from 2012 Eu-SPRI Conference, Karlruhe, Baden-Württemberg, Germany.
2011
Wetenschappelijke publicaties
Nahuis, R., & Boon, W. P. C. (2011). The impact of patient advocacy: the case of innovative breast cancer drug reimbursement. Sociology of Health and Illness, 33(1), 1-15. [DOI] [Repository]
Roelofsen, A., Boon, W. P. C., Kloet, R. R., & Broerse, J. E. W. (2011). Stakeholder interaction within research consortia on emerging technologies: Learning how and what? Research Policy, 40(3), 341-354. [DOI] [Repository]
Boon, W. P. C., Moors, E. H. M., Kuhlmann, S., & Smits, R. E. H. M. (2011). Demand articulation in emerging technologies: intermediary user organizations as co-producers? Research Policy, 40(2), 242-252. [DOI] [Repository]
Moors, E. H. M., Boon, W. P. C., Nahuis, R., & Vandeberg, R. L. J. (2011). User-Producer Interactions in Emerging Pharmaceutical and Food Innovations. In F. Flowers, & F. Henwood (Eds.), Perspectives on User Innovation (pp. 161-188). (Series on Technology Management; No. Vol. 16, Chapter 7). Imperial College Press. [DOI] [Repository]
Vakpublicaties
Boon, W. (2011). Doelmatigheidsonderzoek weesgeneesmiddelen – analyse en toekomstperspectief. Stuurgroep Weesgeneesmiddelen. [Repository]
2010
Wetenschappelijke publicaties
Boon, W., Moors, E., & Leufkens, H. (2010). Patient advocacy and articulation of expectations about pharmaceutical innovations. (Innovation Studies Utrecht (ISU) Working Paper Series). http://www.geo.uu.nl/isu/pdf/isu1001.pdf
Boon, WOUTER., & Heimeriks, G. (2010). Innovation in Europe - three questions. Nature, 468(7322), 377. [DOI] [Repository]
Smit, C., Boon, W. P. C., Evers, M. P. J., Meyboom, R. H. B., & Visser, E. (2010). Tweede evaluatie WMO: Aandacht voor de positie van het prefpersonenlid en de patient is dringend gewenst. Tijdschrift voor Gezondheidsrecht, 4, 305-306. [DOI] [Repository]
Boon, W. P. C., Moors, E. H. M., Meijer, A., & Schellekens, H. (2010). Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe. Clinical Pharmacology and Therapeutics, 88(6), 848-853. [DOI] [Repository]
Boon, W. P. C., Moors, E. H. M., & Meijer, A. (2010). Governing ex-post drug risk surveillance: linking different epistemic cultures. In EASST 010 - Practicing science and technology, performing the social [Repository]
Boon, W., & Broekgaarden, R. (2010). The role of patient advocacy organisations in neuromuscular disease R&D - The case of the Dutch neuromuscular disease association VSN. Neuromuscular Disorders, 20(2), 148-151. [DOI] [Repository]
van Lente, H., Boon, W. P. C., & Klerkx, L. (2010). Positioning of innovation intermediary organisations. In 9th Wageningen International Conference on Chain and Network Management
Vakpublicaties
Boon, W., Geurs, K., & Van Wee, B. (2010). Deel 4: Sociale effecten van verkeer. In B. van Wee, & J.-A. Annema (Eds.), Verkeer en vervoer in hoofdlijnen – capita selecta Uitgeverij Coutinho.
Boerse, J., Boon, W. P. C., & vand er Kraats, J. (2010). Genomics/genetica en de zorgverzekering: Toekomstverkenning van de gevolgen voor de zorgverzekering. Unknown Publisher.
Overige resultaten
Moors, E. H. M., Meijer, A. J., & Boon, W. P. C. (2010, Jul 7). Organizer 2nd Valorisation workshop NWO - Responsible Innovation project on New Modes of Governing Pharmacovigilance.
Boon, W. P. C., Moors, E. H. M., & Meijer, A. J. (2010). Ex-postdrug risk surveillance: Linking different epistemic cultures. Paper. Paper presented at Annual Conference of the European Association for the Study of Science and technology, Trento.
Moors, E. H. M., Meijer, A. J., & Boon, W. P. C. (2010, Jan 21). Organizer 1st Valorisation workshop NWO - Responsible Innovation project on New Modes of Governing Pharmacovigilance.
2009
Wetenschappelijke publicaties
Boon, W. P. C., & van Merkerk, R. O. (2009). Prospective positioning of industrial players: The case of theranostics. Technology Analysis and Strategic Management, 21(4), 471-489. [DOI] [Repository]
Boon, W. (2009). Anticipating emerging genomics technologies: The role of patents and publication for research and policy strategies. Genomics, Society and Policy, 5(2), 1-21. [Repository]
Geurs, K. T., Boon, W. P. C., & van Wee, G. P. (2009). Social impacts of transport: literature review and the state of the practice of transport appraisal in the Netherlands and the United Kingdom. Transport reviews: A Transnational Transdisciplinary Journal, 29(1), 69-90. [DOI] [Repository]
Overige resultaten
Moors, E. H. M., Boon, W. P. C., & Meijer, A. (2009). New Modes of Governing Pharmacovigilance. Poster session presented at Poster presentation N.W.O.-MVI Meeting at Nemo, Amsterdam, The Netherlands.
2008
Wetenschappelijke publicaties
Smits, R., & Boon, W. P. C. (2008). The role of users in innovation in the pharmaceutical industry. Drug Discovery Today, 13(7-8), 353-359. [DOI] [Repository]
Boon, W. P. C., Moors, E. H. M., Kuhlmann, S., & Smits, R. E. H. M. (2008). Demand articulation in intermediary organisations: The case of orphan drugs in the Netherlands. Technological Forecasting and Social Change, 75(5), 644-671. [DOI] [Repository]
Boon, W. P. C. (2008). Demanding Dynamics - Demand articulation of intermediary organisations in emerging pharmaceutical innovations. [Doctoral thesis 1 (Research UU / Graduation UU), Utrecht University]. Utrecht University. [Repository]
Moors, E. H. M., Boon, W. P. C., Nahuis, R., & Vandeberg, R. (2008). User-producer interactions in emerging pharmaceutical and food innovations. International Journal of Innovation Management, 12(3), 459-487. [Repository]
Boon, W., & Moors, E. (2008). Exploring emerging technologies using metaphors - A study of orphan drugs and pharmacogenomics. Social Science & Medicine, 66(9), 1915-1927. [DOI] [Repository]
2007
Wetenschappelijke publicaties
van Merkerk, R. O., & Boon, W. P. C. (2007). Industry strategies on theranostics: Need for structural alignment. Drug Discovery World, 8(4), 61-69. [Repository]
2006
Wetenschappelijke publicaties
Roelofsen, A., & Boon, W. P. C. (2006). Exploring visions as technologies emerge. In W. Vroom (Ed.), Genomics in society, from intentions to implementations
2004
Wetenschappelijke publicaties
Boon, W. P. C., & Cox, R. (2004). Policy benchmarking: demand oriented innovation policy in the Netherlands. Contribution to Policy Benchmarking: demand oriented innovation policy. Fraunhofer Institute Systems and Innovation research.
Overige resultaten
Boon, W. P. C. (2004). Sociale effecten van verkeer. Coutinho.
2003
Overige resultaten
Boon, W., Van Wee, B., & Geurs, K. T. (2003). Severance through infrastructure: A2 en Amsterdam-Rijnkanaal barriers for inhabitants of Utrecht-Leidsche Rijn?. Paper presented at Colloquium Vervoersplanologisch Speurwerk, Amsterdam.